Advertisement
Advertisement

ENGN

ENGN logo

enGene Holdings Inc. Common Stock

9.54
USD
Sponsored
-0.73
-7.16%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

10.35

+0.81
+8.55%

ENGN Earnings Reports

Positive Surprise Ratio

ENGN beat 2 of 7 last estimates.

29%

Next Report

Date of Next Report
Mar 02, 2026
Estimate for Q1 26 (Revenue/ EPS)
--
/
-$0.56
Implied change from Q4 25 (Revenue/ EPS)
--
/
-23.29%
Implied change from Q1 25 (Revenue/ EPS)
--
/
+16.67%

enGene Holdings Inc. Common Stock earnings per share and revenue

On Dec 22, 2025, ENGN reported earnings of -0.73 USD per share (EPS) for Q4 25, missing the estimate of -0.57 USD, resulting in a -25.95% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +5.13% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 11 analysts forecast an EPS of -0.56 USD, with revenue projected to reach -- USD, implying an decrease of -23.29% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q4 2025, enGene Holdings Inc. Common Stock reported EPS of -$0.73, missing estimates by -25.95%, and revenue of $0.00, 0% as expectations.
The stock price moved up 5.13%, changed from $8.77 before the earnings release to $9.22 the day after.
The next earning report is scheduled for Mar 02, 2026.
Based on 11 analysts, enGene Holdings Inc. Common Stock is expected to report EPS of -$0.56 and revenue of -- for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement